JOURNAL OF CLINICAL SURGERY ›› 2025, Vol. 33 ›› Issue (10): 1069-1072.doi: 10.3969/j.issn.1005-6483.20241583

Previous Articles     Next Articles

The application value of serum heat shock protein 70,Periostin combined with low-dose spiral CT in early diagnosis of lung cancer

WANG Shaohua*,WANG Chunrong,HUANG Xiaoyan,LIU Yongbin,LIU Zhixin   

  1. *Department of Radiology,Nanshan District People's Hospital,Shenzhen 518052,China
  • Received:2024-09-29 Online:2025-11-11 Published:2025-11-11

Abstract: Objective To explore the early diagnostic value of serum heat shock protein 70 (HSP70),periosten combined with low-dose spiral CT (LDCT) for lung cancer.Methods From July 2022 to June 2024,103 lung cancer patients admitted to our hospital were regarded as the lung cancer group,and 87 patients with benign pulmonary nodules were selected as the benign group.ELISA kit was used to measure serum HSP70 and Periostin.Multivariate Logistic regression was applied to analyze the influencing factors of lung cancer.Four grid table method was applied to calculate the sensitivity,specificity,and accuracy of LDCT combined with serum HSP70 and Periostin in the diagnosis of lung cancer.Kappa test was applied to evaluate the consistency between LDCT,serum HSP70,Periostin combined with LDCT and pathological diagnosis of lung cancer.Results Compared with the benign group,the lung cancer group had greatly higher levels of serum HSP70 and Periostin (P<0.05).Compared to the benign group,the lung cancer group had higher proportions of lobulation and spiculation signs (P<0.05).Multivariate Logistic regression showed that HSP70 (OR=1.569),Periostin (OR=1.427),lobulation sign (OR=2.015),and spiculation sign (OR=1.946) were all independent risk factors for lung cancer (P<0.05).The sensitivity,specificity,and accuracy of LDCT in diagnosing lung cancer were 85.44%,88.51%,and 86.84%,respectively;the sensitivity,specificity,and accuracy of serum HSP70 and Periostin combined with LDCT in diagnosing lung cancer were 93.20%,80.46%,and 87.37%,respectively.Kappa test showed that the consistency between serum HSP70,Periostin combined with LDCT had high consistency with pathology in the diagnosis of lung cancer (Kappa value=0.743).Conclusion The serum levels of HSP70 and Periostin are higher in lung cancer patients.The combination of serum HSP70 and Periostin with LDCT has better diagnostic efficacy for lung cancer.

Key words: lung cancer, low dose spiral CT, heat shock protein 70, periostin, diagnostic value

[1] . Advances in perioperative therapy for non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 933-937.
[2] . Hot topics and research advances in perioperative immunotherapy for non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 938-942.
[3] . Opportunities and challenges of neoadjuvant immunotherapy innon-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 943-947.
[4] . Expression of long non-coding RNA XIST and microRNA-186-5p in non-small cell lung cancer tissue and their correlation with pathological features [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 953-957.
[5] . Progress in the application of non-intubated video-assisted thoracoscopic surgery for non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(9): 1003-1006.
[6] XU Ruixin, WANG Haoli, ZHANG Wenwei, BIAN Hongchun. Effect and safety of indocyanine green fluorescent staining method in 3D video-assisted thoracoscopic segment resection for stage Ⅰ lung cancer patients were observed [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(8): 822-826.
[7] HUANG Zhigang, ZHANG Xingwei, ZHANG Yu, ZOU Qingxu. The expression of N-acetyltransferase 10,serine hydroxymethyltransferase 2,YTH domain family protein 1 in lung cancer tissues and their correlation with clinicopathological characteristics and prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(8): 827-831.
[8] NIU Lei,HUO Chengyu,LIU Zongzhi. The relationship between fibrinogen to albumin ratio,PNI,SII index and prognosis of patients with lung cancer undergoing thoracoscopic surgery [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(7): 708-.
[9] LIANG Zhiwei, XIN Xing, YU Huimin. The expression and clinical value of lncRNA GAS5 and MMP9 in the serum of patients with non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(5): 498-502.
[10] QIU Rui,LIU Yang,MA Bo,LYU Zhiping,MA Yunfan. The correlation between ERCC6L expression and clinicopathological characteristics and its prognostic significance in non-small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(3): 266-270.
[11] GONG Shunsong,ZHU Yan,DONG Shi,CAI Yixin. Expression of PROM2,RALY and Rab15 in non-small cell lung cancer and their value in predicting the development of bone metastases [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(3): 271-274.
[12] PENG Rongrong, BIAN Jiarong, TAN Wangrong. Clinical significance of the combination of serum neuron specific enolase,stromal cell-derived factor-1,and decoy receptor 3 in prognostic evaluation of non-small cell lung cancer patients [J]. JOURNAL OF CLINICAL SURGERY, 2025, 33(1): 92-96.
[13] ZHAO Jie,JIANG Fan,QI Tao,YAN Lijuan,JIAN Ge,LIU Mengting. Study on the relationship between the expression of miR-30a-5p and miR-129-5p in serum of patients with non-small cell lung cancer after epidermal growth factor receptor targeted therapy and the therapeutic effect [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(9): 923-926.
[14] CHEN Yingkai,YAN Ming. The diagnostic value of plasma exosomes miR-93 for malignant pleural effusion [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(9): 932-935.
[15] YU Letao, XIA Guoqing, YIN Yuliang. Effects of three different patient-controlled analgesia protocols on sedation and analgesia in patients undergoing thoracoscopic surgery for lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2024, 32(8): 882-886.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!